DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03018054 (ClinicalTrials.gov)	November 28, 2016	10/1/2017	Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis	A Phase 2, Double-Blind, Parallel-Group, Placebo-Controlled Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis	Moderate Active Ulcerative Colitis	Drug: E6007;Drug: Placebo	EA Pharma Co., Ltd.	NULL	Completed	20 Years	74 Years	All	147	Phase 2	Japan

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

November 28, 2016

10/1/2017

Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis

A Phase 2, Double-Blind, Parallel-Group, Placebo-Controlled Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis

Moderate Active Ulcerative Colitis

Drug: E6007;Drug: Placebo

EA Pharma Co., Ltd.

NULL

Completed

20 Years

74 Years

All

147

Phase 2

Japan